|
KIAA0776 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.09339997850833E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.56240000007635E-07 |
| Normal-vs-Stage2 |
3.57170000000462E-05 |
| Normal-vs-Stage3 |
6.07630001869808E-09 |
| Normal-vs-Stage4 |
3.90040000297631E-08 |
| Stage1-vs-Stage2 |
4.776000E-01 |
| Stage1-vs-Stage3 |
3.039800E-02 |
| Stage1-vs-Stage4 |
4.598200E-02 |
| Stage2-vs-Stage3 |
4.161600E-01 |
| Stage2-vs-Stage4 |
3.087800E-01 |
| Stage3-vs-Stage4 |
7.582200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05319999785547E-09 |
| Normal-vs-AfricanAmerican |
6.298700E-03 |
| Normal-vs-Asian |
3.85680000047905E-07 |
| Caucasian-vs-AfricanAmerican |
5.167000E-01 |
| Caucasian-vs-Asian |
5.327200E-01 |
| AfricanAmerican-vs-Asian |
4.307000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50080001151787E-09 |
| Normal-vs-Female |
1.17429999946239E-07 |
| Male-vs-Female |
9.472000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85678999999883E-05 |
| Normal-vs-Age(41-60Yrs) |
5.65669999730289E-09 |
| Normal-vs-Age(61-80Yrs) |
9.6852999953434E-08 |
| Normal-vs-Age(81-100Yrs) |
3.296900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.543900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.231600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.801800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.223600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.226800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.557600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.255800E-01 |
| Classical-VS-Follicular |
9.467200E-01 |
| Classical-VS-Other |
4.379600E-01 |
| Classical-VS-Normal |
1.98900000025759E-07 |
| Tall-VS-Follicular |
2.053000E-01 |
| Tall-VS-Other |
8.564800E-01 |
| Tall-VS-Normal |
1.5860499999909E-05 |
| Follicular-VS-Other |
4.699800E-01 |
| Follicular-VS-Normal |
6.18519999999734E-05 |
| Other-VS-Normal |
7.978800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18289999806854E-08 |
| Normal-vs-N1 |
9.5441000003138E-07 |
| N0-vs-N1 |
7.627600E-01 |
|
|
